Between Feb 6 , 2009 , and Nov 27 , 2013 , we enrolled 492 patients and randomly assigned 247 to desmoteplase and 245 to placebo ( 236 in the desmoteplase group and 237 in the placebo group were included in the analysis of the primary endpoint ) .